Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome.
about
sameAs
Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women.Can early therapy reduce inflammation?Aspirin: a review of its neurobiological properties and therapeutic potential for mental illnessAnti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyAssociation between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialUrinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Association between use of specialty dietary supplements and C-reactive protein concentrations.Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trial.An eicosanoid-centric view of atherothrombotic risk factorsLifestyle factors and inflammation: associations by body mass indexInflammatory markers in coronary heart disease.Inflammatory mediators involved in the progression of the metabolic syndrome.Aspirin for primary prevention of cardiovascular events in the elderly: current status and future directions.Drug-disease interactions: narrative review of aspirin in gastric ulcer.Inflammation and the Silent Sequelae of Stroke.Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities.Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.ASPREE-D: Aspirin for the prevention of depression in the elderly.
P2860
Q30278840-3D6F4B59-C5D6-4F79-B110-5DE4B536D2F6Q33728638-192E8ABE-FBDC-4FEB-8903-8AA3394DC0F4Q33728638-B914FBB7-A701-436A-8AAC-8E4089D53183Q34159822-F1419D5F-97CD-4F71-BF4A-B0CF7D8C2712Q34626598-CB2A5FAD-685F-4A9B-8A53-BCE78E9D1847Q34626598-E82D0045-396E-46AB-A6ED-BB5E187EBCD4Q35373624-72936E73-B5A8-4CED-AE0A-B9E916B3EB66Q35562771-A6C4B017-A1E0-4529-9253-553C5E78F44CQ36248969-8F0BBB2F-5F2B-4936-9380-3F8684AF05BFQ36606633-A7D38CC5-125E-4168-A23B-A8801B63E168Q36606633-C27B4174-CAAB-40CF-8F7F-C6DAD12355DBQ36785606-96B88AC6-D298-4D86-87D7-9DB0DA4A8506Q36785606-A239CF13-32D9-4017-8A1E-B6BF384321E4Q36952174-90392BBB-1C50-4A5E-92BE-3657AA317801Q36952174-C9EA4965-D1D5-4AAC-98D9-2FE2A43C327FQ36976367-2E157877-883C-48F5-BD72-2C0ED37687A0Q36976367-8D6B841E-D0D4-4C73-A473-4C8C596A88D8Q37947242-74789DEE-61FB-4D04-8B3A-E19498202D61Q37990459-805877EC-3701-41AB-85EA-1E4E335BFB80Q37998509-38B833E3-B42D-4F12-B9D6-9E1395497036Q38870495-9958ADA6-180B-406E-8C3E-620334FA95B8Q38871034-22389EEA-00D9-476E-A0D4-01AEB6C7D958Q38871034-970F5DF7-5501-48F3-BCBB-548421ABD4A4Q38914613-0BC5F80D-9D66-45DA-886E-F6D7C544AECFQ38914613-1105930B-2AB0-4293-A34B-C78275C8DD3FQ40282636-1DE0D03F-ED9E-42CF-A2F9-265CEC0BCD11Q48042512-2D202878-C282-44B4-8865-A76998CAD358
P2860
Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Efficacy of different doses of ...... iovascular metabolic syndrome.
@en
Efficacy of different doses of ...... iovascular metabolic syndrome.
@nl
type
label
Efficacy of different doses of ...... iovascular metabolic syndrome.
@en
Efficacy of different doses of ...... iovascular metabolic syndrome.
@nl
altLabel
Efficacy of different doses of ...... diovascular metabolic syndrome
@en
Efficacy of different doses of ...... diovascular metabolic syndrome
@nl
prefLabel
Efficacy of different doses of ...... iovascular metabolic syndrome.
@en
Efficacy of different doses of ...... iovascular metabolic syndrome.
@nl
P2093
P2860
P921
P1476
Efficacy of different doses of ...... diovascular metabolic syndrome
@en
Efficacy of different doses of ...... iovascular metabolic syndrome.
@en
P2093
Chandar M Adhikari
Chandar M. Adhikari
Li-Yuan Zhang
Long-Yun Peng
Long-yun Peng
Xiao-Gang Guo
Xiao-gang Guo
Xiu-Ren Gao
Xiu-ren Gao
P2860
P304
P356
10.1211/JPP.61.11.0010
10.1211/JPP/61.11.0010
P50
P577
2009-11-01T00:00:00Z